NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- via IBN – AI Maverick Intel Inc. (OTC: AIMV), a technology-driven innovator focused on redefining how businesses acquire and engage customers through artificial intelligence, today announced that effective Oct. 20, 2025, the Company’s common shares will commence trading on the OTC Market under its new ticker symbol “AIMV.” This change follows the Company’s previously announced rebranding from Bionoid Pharma, Inc. to AI Maverick Intel, Inc., reflecting its strategi ...